China has approved a new weight-loss drug that is poised to rival Novo Nordisk and Eli Lilly's popular GLP-1 treatments, ...

This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

The diabetes conference featured a debate about over-the-counter glucose monitors and updates on upcoming devices, including ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...

Other trials are testing whether the drug can treat sleep apnoea or type 2 diabetes. The growing number of new GLP-1 drugs target multiple pathways at the same time so will result in more-tailored ...

A promising new insulin pill is just several months away from being trialled by people living with diabetes in ...

The study looked at a drug called spironolactone. It’s normally used to treat high blood pressure, but it’s now showing ...

One of the main researchers, Professor Tore Bengtsson from Stockholm University, said this could be an exciting step forward.